The present invention relates to a pharmaceutical composition for preventing or treating acute myeloid leukemia or metastatic breast cancer, comprising, as an active ingredient, an indirubin derivative. When the compound of the present invention is used, it can effectively inhibit the activity of FLT3 kinase and can be usefully used to prevent or treat acute myeloid leukemia or metastatic breast cancer.
本发明涉及一种用于预防或治疗急性髓性白血病或转移性乳腺癌的药物组合物,其活性成分包括一种
靛红衍
生物。当使用本发明的化合物时,它可以有效地抑制FLT3激酶的活性,可用于预防或治疗急性髓性白血病或转移性乳腺癌。